Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LISP.SW Stock Summary
Top 10 Correlated ETFs
LISP.SW
In the News
LISP.SW Financial details
Company Rating
Buy
Market Cap
24.24B
Income
1.24B
Revenue
10.17B
Book val./share
1833.98
Cash/share
199.22
Dividend
130
Dividend %
1.27%
Employees
14.5K
Optionable
No
Shortable
Yes
Earnings
23 Jul 2024
P/E
84.85
Forward P/E
-
PEG
7.1
P/S
9.74
P/B
5.55
P/C
51.75
P/FCF
91.97
Quick Ratio
0.4
Current Ratio
1.84
Debt / Equity
0.33
LT Debt / Equity
0.25
-
-
EPS (TTM)
530.47
EPS next Y
-
EPS next Q
-
EPS this Y
19.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.17%
Revenue last 5Y
2.83%
Revenue Q/Q
49.4%
EPS Q/Q
129.17%
-
-
-
-
SMA20
-6.34%
SMA50
-6.78%
SMA100
-4.02%
Inst Own
0%
Inst Trans
0%
ROA
4%
ROE
9%
ROC
0.06%
Gross Margin
66%
Oper. Margin
15%
Profit Margin
11%
Payout
50%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9385.0-11430.0
52W High
-9.8%
52W Low
+9.86%
RSI
35.83
Rel Volume
0.57
Avg Volume
2.45K
Volume
1.41K
Perf Week
-0.29%
Perf Month
-5.84%
Perf Quarter
4.94%
Perf Half Y
4.88%
-
-
-
-
Beta
0.312
-
-
Volatility
52.61%, 309.15%
Prev Close
-0.29%
Price
10310
Change
0.49%
LISP.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.9K | 1.66K | 1.92K | 2.11K | 2.24K | |
Net income per share | 214.15 | 133.31 | 204.88 | 241.59 | 288.88 | |
Operating cash flow per share | 349.18 | 326.38 | 345.35 | 320.6 | 335 | |
Free cash flow per share | 261.18 | 223.15 | 244.85 | 223.19 | 205.15 | |
Cash per share | 445.45 | 518.04 | 496.01 | 366.78 | 199 | |
Book value per share | 1.96K | 1.91K | 2.18K | 1.87K | 1.83K | |
Tangible book value per share | 1.39K | 1.08K | 1.33K | 992.02 | 1.3K | |
Share holders equity per share | 1.96K | 1.91K | 2.18K | 1.87K | 1.83K | |
Interest debt per share | 465 | 454.97 | 463.89 | 468.09 | 619.32 | |
Market cap | 17.88B | 20.83B | 30.24B | 22.24B | 23.45B | |
Enterprise value | 18.71B | 21.44B | 30.78B | 22.81B | 24.39B | |
P/E ratio | 35.09 | 64.74 | 61.65 | 39.03 | 34.93 | |
Price to sales ratio | 3.95 | 5.18 | 6.59 | 4.47 | 4.51 | |
POCF ratio | 21.52 | 26.44 | 36.57 | 29.41 | 30.12 | |
PFCF ratio | 28.77 | 38.67 | 51.58 | 42.25 | 49.18 | |
P/B Ratio | 3.84 | 4.53 | 5.79 | 5.05 | 5.51 | |
PTB ratio | 3.84 | 4.53 | 5.79 | 5.05 | 5.51 | |
EV to sales | 4.14 | 5.34 | 6.71 | 4.59 | 4.69 | |
Enterprise value over EBITDA | 21.84 | 30.8 | 33.41 | 22.41 | 22.14 | |
EV to operating cash flow | 22.52 | 27.22 | 37.23 | 30.17 | 31.33 | |
EV to free cash flow | 30.11 | 39.81 | 52.51 | 43.34 | 51.16 | |
Earnings yield | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | |
Free cash flow yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Debt to equity | 0.23 | 0.23 | 0.21 | 0.24 | 0.33 | |
Debt to assets | 0.13 | 0.13 | 0.12 | 0.13 | 0.18 | |
Net debt to EBITDA | 0.97 | 0.88 | 0.59 | 0.56 | 0.86 | |
Current ratio | 1.76 | 2.31 | 2.04 | 1.83 | 1.42 | |
Interest coverage | 19.39 | 15.6 | 23.89 | 25.34 | 24.2 | |
Income quality | 1.63 | 2.45 | 1.69 | 1.33 | 1.16 | |
Dividend Yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.46 | 1.3 | 0.54 | 0.5 | 0.45 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.17 | 0.25 | 0.22 | 0.25 | 0.16 | |
Capex to operating cash flow | -0.25 | -0.32 | -0.29 | -0.3 | -0.39 | |
Capex to revenue | -0.05 | -0.06 | -0.05 | -0.05 | -0.06 | |
Capex to depreciation | -0.82 | -0.99 | -0.89 | -0.87 | -1.13 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Graham number | 3.07K | 2.39K | 3.17K | 3.18K | 3.45K | |
ROIC | 0.1 | 0.06 | 0.08 | 0.1 | 0.11 | |
Return on tangible assets | 0.08 | 0.05 | 0.07 | 0.09 | 0.1 | |
Graham Net | -506.47 | -509.53 | -639.23 | -672.11 | -791.97 | |
Working capital | 1.29B | 1.67B | 1.54B | 1.31B | 766M | |
Tangible asset value | 3.3B | 2.6B | 3.18B | 2.34B | 3.02B | |
Net current asset value | -394.9M | -588.2M | -827.5M | -800.3M | -993.4M | |
Invested capital | 0.23 | 0.23 | 0.21 | 0.24 | 0.33 | |
Average receivables | 998.5M | 961.35M | 976.85M | 1.04B | 1.09B | |
Average payables | 224.05M | 210.65M | 212.65M | 264.2M | 298.2M | |
Average inventory | 751.15M | 725.8M | 731.55M | 818.6M | 898.55M | |
Days sales outstanding | 78.55 | 86.22 | 79.98 | 78.58 | 78.46 | |
Days payables outstanding | 56.37 | 26.74 | 31.31 | 35.93 | 65.44 | |
Days of inventory on hand | 180.78 | 100.08 | 100.23 | 108.3 | 197.14 | |
Receivables turnover | 4.65 | 4.23 | 4.56 | 4.65 | 4.65 | |
Payables turnover | 6.47 | 13.65 | 11.66 | 10.16 | 5.58 | |
Inventory turnover | 2.02 | 3.65 | 3.64 | 3.37 | 1.85 | |
ROE | 0.11 | 0.07 | 0.09 | 0.13 | 0.16 | |
Capex per share | -88 | -103.23 | -100.5 | -97.41 | -129.85 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.16K | 841.44 | 1.26K | 894.98 | 1.34K | |
Net income per share | 162.54 | 58.47 | 183.12 | 87.76 | 201.12 | |
Operating cash flow per share | 194.43 | 137.47 | 182.82 | 122.52 | 212.41 | |
Free cash flow per share | 149.75 | 86.18 | 136.84 | 58.92 | 146.24 | |
Cash per share | 496.3 | 335.57 | 367.22 | 207.62 | 199.22 | |
Book value per share | 2.18K | 1.85K | 1.87K | 1.87K | 1.83K | |
Tangible book value per share | 1.33K | 1.28K | 993.22 | 1.31K | 1.3K | |
Share holders equity per share | 2.18K | 1.85K | 1.87K | 1.87K | 1.83K | |
Interest debt per share | 459.19 | 460.28 | 463.26 | 467.12 | 616.45 | |
Market cap | 30.22B | 22.98B | 22.21B | 26.19B | 23.42B | |
Enterprise value | 30.76B | 23.65B | 22.78B | 27.13B | 24.37B | |
P/E ratio | 19.43 | 41.52 | 12.87 | 32.02 | 12.54 | |
Price to sales ratio | 10.85 | 11.54 | 7.46 | 12.56 | 7.52 | |
POCF ratio | 64.96 | 70.63 | 51.58 | 91.74 | 47.5 | |
PFCF ratio | 84.34 | 112.67 | 68.91 | 190.76 | 69 | |
P/B Ratio | 5.79 | 5.23 | 5.05 | 6.01 | 5.5 | |
PTB ratio | 5.79 | 5.23 | 5.05 | 6.01 | 5.5 | |
EV to sales | 11.04 | 11.88 | 7.65 | 13.01 | 7.82 | |
Enterprise value over EBITDA | 46.99 | 74.31 | 32.57 | 70.84 | 34.28 | |
EV to operating cash flow | 66.13 | 72.68 | 52.91 | 95.03 | 49.42 | |
EV to free cash flow | 85.86 | 115.94 | 70.68 | 197.6 | 71.77 | |
Earnings yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.21 | 0.25 | 0.24 | 0.25 | 0.33 | |
Debt to assets | 0.12 | 0.14 | 0.13 | 0.14 | 0.18 | |
Net debt to EBITDA | 0.83 | 2.1 | 0.82 | 2.45 | 1.33 | |
Current ratio | 2.04 | 1.87 | 1.83 | 1.84 | 1.42 | |
Interest coverage | 32.86 | 14.58 | 32.91 | 21.61 | 22.06 | |
Income quality | 1.2 | 2.35 | 1 | 1.4 | 1.06 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.82 | 2.05 | 0.47 | 1.48 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0.22 | 0.18 | 0.25 | 0.17 | 0.16 | |
Capex to operating cash flow | -0.23 | -0.37 | -0.25 | -0.52 | -0.31 | |
Capex to revenue | -0.04 | -0.06 | -0.04 | -0.07 | -0.05 | |
Capex to depreciation | -0.72 | -0.91 | -0.77 | -1.16 | -1.01 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | -0.23 | |
Graham number | 2.83K | 1.56K | 2.77K | 1.92K | 2.88K | |
ROIC | 0.06 | 0.02 | 0.08 | 0.04 | 0.08 | |
Return on tangible assets | 0.06 | 0.02 | 0.07 | 0.03 | 0.07 | |
Graham Net | -639.62 | -694.92 | -672.92 | -775.78 | -792.87 | |
Working capital | 1.54B | 1.1B | 1.31B | 1.02B | 766M | |
Tangible asset value | 3.18B | 3.04B | 2.34B | 3.06B | 3.02B | |
Net current asset value | -827.5M | -952.6M | -800.3M | -1.03B | -993.4M | |
Invested capital | 0.21 | 0.25 | 0.24 | 0.25 | 0.33 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 32.46 | 22.96 | 32.33 | 22.57 | 32.29 | |
Days payables outstanding | 13.38 | 14.36 | 15.25 | 15.27 | 15.6 | |
Days of inventory on hand | 42.84 | 71.42 | 45.96 | 82.22 | 46.98 | |
Receivables turnover | 2.77 | 3.92 | 2.78 | 3.99 | 2.79 | |
Payables turnover | 6.73 | 6.27 | 5.9 | 5.89 | 5.77 | |
Inventory turnover | 2.1 | 1.26 | 1.96 | 1.09 | 1.92 | |
ROE | 0.07 | 0.03 | 0.1 | 0.05 | 0.11 | |
Capex per share | -44.68 | -51.29 | -45.98 | -63.6 | -66.16 |
LISP.SW Frequently Asked Questions
What is Chocoladefabriken Lindt & Sprüngli AG stock symbol ?
Chocoladefabriken Lindt & Sprüngli AG is a CH stock and trading under the symbol LISP.SW
What is Chocoladefabriken Lindt & Sprüngli AG stock quote today ?
Chocoladefabriken Lindt & Sprüngli AG stock price is $10310 today.
Is Chocoladefabriken Lindt & Sprüngli AG stock public?
Yes, Chocoladefabriken Lindt & Sprüngli AG is a publicly traded company.